Andrei Shustov
Direttore Tecnico/Scientifico/R&S presso CELLECTAR BIOSCIENCES, INC.
Patrimonio netto: 170 064 $ in data 31/05/2024
Profilo
Andrei Shustov is currently a Senior Vice President-Medical at Cellectar Biosciences, Inc. He previously worked as a Senior Medical Director-Late Stage Clinical at Seagen Inc. Shustov earned a doctorate degree from S.
I.
Georgievsky's Medical Academy in 1987.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/06/2024 | 55 037 ( 0.15% ) | 170 064 $ | 31/05/2024 |
Posizioni attive di Andrei Shustov
| Società | Posizione | Inizio |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 15/02/2023 |
Precedenti posizioni note di Andrei Shustov
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
Formazione di Andrei Shustov
| S. I. Georgievsky's Medical Academy | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Andrei Shustov
